BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 30208826)

  • 1. Translation Factor eIF5A, Modification with Hypusine and Role in Regulation of Gene Expression. eIF5A as a Target for Pharmacological Interventions.
    Turpaev KT
    Biochemistry (Mosc); 2018 Aug; 83(8):863-873. PubMed ID: 30208826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Posttranslational synthesis of hypusine: evolutionary progression and specificity of the hypusine modification.
    Wolff EC; Kang KR; Kim YS; Park MH
    Amino Acids; 2007 Aug; 33(2):341-50. PubMed ID: 17476569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional significance of eIF5A and its hypusine modification in eukaryotes.
    Park MH; Nishimura K; Zanelli CF; Valentini SR
    Amino Acids; 2010 Feb; 38(2):491-500. PubMed ID: 19997760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of active recombinant eIF5A: reconstitution in E.coli of eukaryotic hypusine modification of eIF5A by its coexpression with modifying enzymes.
    Park JH; Dias CA; Lee SB; Valentini SR; Sokabe M; Fraser CS; Park MH
    Protein Eng Des Sel; 2011 Mar; 24(3):301-9. PubMed ID: 21131325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The translation factor eIF5A and human cancer.
    Mathews MB; Hershey JW
    Biochim Biophys Acta; 2015 Jul; 1849(7):836-44. PubMed ID: 25979826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity of the deoxyhypusine hydroxylase-eukaryotic translation initiation factor (eIF5A) interaction: identification of amino acid residues of the enzyme required for binding of its substrate, deoxyhypusine-containing eIF5A.
    Kang KR; Kim YS; Wolff EC; Park MH
    J Biol Chem; 2007 Mar; 282(11):8300-8. PubMed ID: 17213197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The post-translational synthesis of a polyamine-derived amino acid, hypusine, in the eukaryotic translation initiation factor 5A (eIF5A).
    Park MH
    J Biochem; 2006 Feb; 139(2):161-9. PubMed ID: 16452303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-translational formation of hypusine in eIF5A: implications in human neurodevelopment.
    Park MH; Kar RK; Banka S; Ziegler A; Chung WK
    Amino Acids; 2022 Apr; 54(4):485-499. PubMed ID: 34273022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypusine, a polyamine-derived amino acid critical for eukaryotic translation.
    Park MH; Wolff EC
    J Biol Chem; 2018 Nov; 293(48):18710-18718. PubMed ID: 30257869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deoxyhypusine Modification of Eukaryotic Translation Initiation Factor 5A (eIF5A) Is Essential for Trypanosoma brucei Growth and for Expression of Polyprolyl-containing Proteins.
    Nguyen S; Leija C; Kinch L; Regmi S; Li Q; Grishin NV; Phillips MA
    J Biol Chem; 2015 Aug; 290(32):19987-98. PubMed ID: 26082486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic drug combination GC7/DFMO suppresses hypusine/spermidine-dependent eIF5A activation and induces apoptotic cell death in neuroblastoma.
    Schultz CR; Geerts D; Mooney M; El-Khawaja R; Koster J; Bachmann AS
    Biochem J; 2018 Jan; 475(2):531-545. PubMed ID: 29295892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of eukaryotic initiation factor 5A (eIF5A) by specific acetylation of its hypusine residue by spermidine/spermine acetyltransferase 1 (SSAT1).
    Lee SB; Park JH; Folk JE; Deck JA; Pegg AE; Sokabe M; Fraser CS; Park MH
    Biochem J; 2011 Jan; 433(1):205-13. PubMed ID: 20942800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recessive Rare Variants in Deoxyhypusine Synthase, an Enzyme Involved in the Synthesis of Hypusine, Are Associated with a Neurodevelopmental Disorder.
    Ganapathi M; Padgett LR; Yamada K; Devinsky O; Willaert R; Person R; Au PB; Tagoe J; McDonald M; Karlowicz D; Wolf B; Lee J; Shen Y; Okur V; Deng L; LeDuc CA; Wang J; Hanner A; Mirmira RG; Park MH; Mastracci TL; Chung WK
    Am J Hum Genet; 2019 Feb; 104(2):287-298. PubMed ID: 30661771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the polyamine-hypusine circuit for the prevention and treatment of cancer.
    Nakanishi S; Cleveland JL
    Amino Acids; 2016 Oct; 48(10):2353-62. PubMed ID: 27357307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of hypusine modification on the intracellular localization of eIF5A.
    Lee SB; Park JH; Kaevel J; Sramkova M; Weigert R; Park MH
    Biochem Biophys Res Commun; 2009 Jun; 383(4):497-502. PubMed ID: 19379712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational analyses of human eIF5A-1--identification of amino acid residues critical for eIF5A activity and hypusine modification.
    Cano VS; Jeon GA; Johansson HE; Henderson CA; Park JH; Valentini SR; Hershey JW; Park MH
    FEBS J; 2008 Jan; 275(1):44-58. PubMed ID: 18067580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The deoxyhypusine synthase mutant dys1-1 reveals the association of eIF5A and Asc1 with cell wall integrity.
    Galvão FC; Rossi D; Silveira Wda S; Valentini SR; Zanelli CF
    PLoS One; 2013; 8(4):e60140. PubMed ID: 23573236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tandem affinity purification revealed the hypusine-dependent binding of eukaryotic initiation factor 5A to the translating 80S ribosomal complex.
    Jao DL; Chen KY
    J Cell Biochem; 2006 Feb; 97(3):583-98. PubMed ID: 16215987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A hypusine-eIF5A-PEAK1 switch regulates the pathogenesis of pancreatic cancer.
    Fujimura K; Wright T; Strnadel J; Kaushal S; Metildi C; Lowy AM; Bouvet M; Kelber JA; Klemke RL
    Cancer Res; 2014 Nov; 74(22):6671-81. PubMed ID: 25261239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amino acid substrates impose polyamine, eIF5A, or hypusine requirement for peptide synthesis.
    Shin BS; Katoh T; Gutierrez E; Kim JR; Suga H; Dever TE
    Nucleic Acids Res; 2017 Aug; 45(14):8392-8402. PubMed ID: 28637321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.